本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

2.24
0.0000
盤後2.23-0.0100-0.45%19:37 EDT
成交量:4.30萬
成交額:9.79萬
市值:479.93萬
市盈率:-0.48
高:2.30
開:2.27
低:2.24
收:2.24
52周最高:13.20
52周最低:2.16
股本:214.25萬
流通股本:214.25萬
量比:0.45
換手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):-4.6460
每股收益(LYR):-1,791.0249
淨資產收益率:-211.37%
總資產收益率:-77.12%
市淨率:0.99
市盈率(LYR):0.00

資料載入中...

2019/10/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/10/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/12

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers